Penserra Capital Management LLC - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 81 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$18,000
+28.6%
900
+7.8%
0.00%
Q2 2021$14,000
-30.0%
835
+1.2%
0.00%
Q1 2021$20,000
-28.6%
825
-1.8%
0.00%
-100.0%
Q4 2020$28,0008400.00%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Column Group LLC 4,768,181$116,820,00011.19%
Memorial Sloan Kettering Cancer Center 602,272$14,756,0009.10%
Euclidean Capital LLC 996,734$24,420,0008.17%
Invus Financial Advisors, LLC 1,007,575$24,686,0005.66%
EcoR1 Capital, LLC 3,092,218$75,759,0003.36%
Ally Bridge Group (NY) LLC 413,061$10,120,0001.94%
EMERALD ADVISERS, LLC 615,511$15,080,0000.54%
Orbimed Advisors 2,337,574$57,271,0000.54%
EMERALD MUTUAL FUND ADVISERS TRUST 624,210$15,293,0000.51%
Casdin Capital, LLC 601,515$14,737,0000.44%
View complete list of ORIC PHARMACEUTICALS INC shareholders